Advertisement
Home Blog Page 1907
From 2015 to 2017

Increase Seen in Opioid-, Synthetic Opioid-Involved OD Deaths

0
From 2015 to 2017, number of opioid-involved overdose deaths increased for nearly all racial/ethnic groups
Many lung cancer patients in the United States receive no treatment or less intensive treatment than recommended

Many Not Receiving Guideline-Concordant Tx for Lung Cancer

0
Elderly, non-Hispanic blacks particularly less likely to receive recommended lung cancer treatment
Only half of oncologists who discuss genomic testing with patients report that they often discuss the likely costs of testing and related treatments

Many Oncologists Fail to Discuss Costs of Genomic Testing

0
About a quarter of oncologists say they rarely, never bring up costs when they discuss genomic testing
For older adults

Hospitalizations May Hasten Cognitive Decline in the Elderly

0
Association more pronounced for those with more tangle pathology, neocortical Lewy bodies
Middle-aged adults with borderline personality disorder seem to have an increased cardiometabolic risk

Borderline Personality Disorder May Raise Cardiometabolic Risk

0
Borderline personality traits, depression associated with extent of midlife cardiometabolic risk
Most estimates show no differences in effectiveness between classes of antihypertensive agents

Equivalence Seen Between Drug Classes for HTN Monotherapy

0
Thiazide, thiazide-like diuretics superior to ACEi; nondihydropyridine calcium channel blockers inferior
Adalimumab exposure in pregnancy does not increase the risk for birth defects

Risk for Birth Defects Not Increased With Adalimumab

0
Risk for preterm delivery higher in women with RA, Crohn disease regardless of adalimumab exposure
Survivors of chronic lymphocytic leukemia have an increased risk for second primary malignancy

Risk for Second Primary Malignancy Up in CLL Survivors

0
SPM risk higher for men and nonwhites, after chemotherapy, for recent years of diagnosis, for advanced age
For patients with cystic fibrosis with Phe508del-minimal function genotypes

Elexacaftor-Tezacaftor-Ivacaftor Efficacious for Cystic Fibrosis

0
Percentage of FEV1 higher at four weeks and through 24 weeks with treatment versus placebo
Since 2012

CDC: Prevalence of Diabetes Has Plateaued Since 2012 for Seniors

0
Prevalence increased from 23.3 percent in 2001 to high of 32.2 percent in 2012, then plateaued